Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mitsugu Tanii"'
Autor:
Koichiro Maeda, Hiroyuki Honda, Sachiko Koyama, Mitsugu Tanii, Toru Iwaki, Masahiro Shijo, Junya Kuroda, Koji Ishitsuka, Takanari Kitazono
Publikováno v:
Neuropathology. 37:275-281
Over 60% of all patients with dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) have been diagnosed in Japan. The incubation period has ranged from 1 to 30 years and the age at onset from 15 to 80 years. Here, we report a 77-year-old male
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce59cd63e578eb12414c6c6c595d5af0
https://doi.org/10.1111/neup.12359
https://doi.org/10.1111/neup.12359
Autor:
Shigeo Koido, Eri Yanagida, Masato Okamoto, Shigetaka Shimodaira, Noboru Suzuki, Yuta Shibamoto, Tomoyo Sakabe, Yoshikazu Yonemitsu, Masaki Nagaya, Masahiro Ogasawara, Hidenori Takahashi, Shunichi Tsujitani, Hirofumi Abe, Asako Chiba, Mitsugu Tanii, Kazuhiro Nagai, Masanori Kobayashi
Publikováno v:
Journal of Gastrointestinal Surgery. 17:1609-1617
The aim of this retrospective study was to clarify the safety and efficacy of dendritic cell (DC)-based immunotherapy targeting synthesized peptides, Wilms tumor 1 (WT1) and Mucin 1, cell surface associated (MUC1) for biliary tract cancers (BTCs). Si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b18edebe5204b6d911d0289b0ad60b
https://doi.org/10.1007/s11605-013-2286-2
https://doi.org/10.1007/s11605-013-2286-2
Autor:
Mitsugu Tanii, Mitsuho Onimaru, Toshiaki Nakano, Katsuo Sueishi, Ri Ichiro Kohno, Kazunori Nakagawa, Takaaki Fujii, Yoshikazu Yonemitsu, Shin Ichi Nishikawa, Mamoru Hasegawa
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 297:H1685-H1696
Emerging evidence indicates that the tight communication between vascular endothelial cells and mural cells using platelet-derived growth factor (PDGF)-BB is essential for capillary stabilization during the angiogenic process. However, little is know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4d12e4a0a83c9b774d35a5aee5a289
https://doi.org/10.1152/ajpheart.00015.2009
https://doi.org/10.1152/ajpheart.00015.2009
Autor:
Mitsuho Onimaru, Kensuke Egashira, Makoto Inoue, Katsuo Sueishi, Takako Takehara, Mitsugu Tanii, Hiroyuki Kuwano, Yoshikazu Yonemitsu, Takaaki Fujii, Mamoru Hasegawa, Toshiaki Nakano
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 26:2483-2489
Objective—Monocyte chemoattractant protein-1 (MCP-1) is a C-C chemokine that is known as an inflammatory/arteriogenic factor. Angiogenesis contributes to the inflammatory process; however, the molecular and cellular mechanisms of the links among th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e912beb166e0b05a29eddae626266670
https://doi.org/10.1161/01.atv.0000244684.23499.bf
https://doi.org/10.1161/01.atv.0000244684.23499.bf
Autor:
Yoshikazu Yonemitsu, Sun-ichi Tsujitani, Hidenori Takahashi, Kazuhiro Nagai, Masahiro Ogasawara, Masaki Nagaya, Shigetaka Shimodaira, Seiichi Yusa, Junji Kishimoto, Mitsugu Tanii, Hirofumi Abe, Masato Okamoto, Yuta Shibamoto, Masanori Kobayashi, Takefumi Ishidao
Publikováno v:
Cancer immunology, immunotherapy : CII. 63(8)
Dendritic cell (DC)-based cancer vaccines may have a significant benefit to patients with advanced pancreatic cancer. However, variations among clinical studies make it difficult to compare clinical outcomes. Here, we identified factors that determin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1ae0b76c47bc87010a139f8d5abf64
https://pubmed.ncbi.nlm.nih.gov/24777613
https://pubmed.ncbi.nlm.nih.gov/24777613
Autor:
Masahiro Ogasawara, Masanori Kobayashi, Hidenori Takahashi, Yoshikazu Yonemitsu, Shimodaira Shigetaka, Shunichi Tsujitani, Kazuhiro Nagai, Mitsugu Tanii, Masato Okamoto, Masaki Nagaya, Hirofumi Abe
Publikováno v:
Cancer Research. 74:2813-2813
Purpose: Dendritic cell (DC)-based cancer vaccine may have a significant benefit to patients with advanced pancreatic cancer. However, variations among clinical studies make it hard to detect its clinical outcome. Here we statistically identified fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78839bf3a5dead141a0ffdcee1b9ae6b
https://doi.org/10.1158/1538-7445.am2014-2813
https://doi.org/10.1158/1538-7445.am2014-2813
Autor:
Tomoyo Sakabe, Hirofumi Abe, Shigetaka Shimodaira, Masaki Nagaya, Masato Okamoto, Yoshikazu Yonemitsu, Mitsugu Tanii, Shunichi Tsujitani, Masanori Kobayashi, Hedenori Takahashi
Publikováno v:
Cancer Research. 73:2840-2840
Objectives:Despite intensive chemotherapy for biliary tract cancer (BTC), the outcome is not enough. Dendritic cells are the powerful antigen-presenting cells that have attracted attention from the efficacy of DC-based immunotherapy against many type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8800e2588e661bd4a29b75e3393aee5
https://doi.org/10.1158/1538-7445.am2013-2840
https://doi.org/10.1158/1538-7445.am2013-2840
Autor:
Makoto Inoue, Katsuo Sueishi, Mitsugu Tanii, Shinji Okano, Mamoru Hasegawa, Toshihiro Onohara, Ri Ichiro Kohno, Mitsuho Onimaru, Yasunori Shikada, Yoshikazu Yonemitsu, Takaaki Fujii, Yoshihiko Maehara
Publikováno v:
Circulation research. 98(1)
Diabetic foot is caused by microangiopathy and is suggested to be a result of impaired angiogenesis. Using a severe hindlimb ischemia model of streptozotocin-induced diabetic mice (STZ-DM), we show that diabetic foot is a disease solely of the distur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed40c486814601d6762b74fb2c39d698
https://pubmed.ncbi.nlm.nih.gov/16397150
https://pubmed.ncbi.nlm.nih.gov/16397150
Autor:
Tetsuro Akashi, Yu Takamatsu, Kazuhide Matsumoto, Risa Hashimoto, Takehiro Takaoka, Mitsugu Tanii
Publikováno v:
JOP Journal of the Pancreas; Sep2017, Vol. 18 Issue 5, p440-443, 4p, 1 Color Photograph, 1 Graph
Autor:
Yoshihiko Maehara, Kazuhiro Kaneko, Katsuo Sueishi, Shinji Okano, Mamoru Hasegawa, Mitsugu Tanii, Yoshikazu Yonemitsu, Yasunori Shikada, Makoto Hashizume, Norifumi Tsutsumi, Mitsuho Onimaru
Publikováno v:
Circulation research. 94(9)
Discovery of the common and ubiquitous molecular targets for the disruption of angiogenesis, that are independent of the characteristics of malignant tumors, is desired to develop the more effective antitumor drugs. In this study, we propose that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a5931c51cf58e80c60f8c7dc142a5f
https://pubmed.ncbi.nlm.nih.gov/15059936
https://pubmed.ncbi.nlm.nih.gov/15059936